ACE genotype and cognitive decline in an African-Caribbean population

Neurobiology of Aging

Volumn 25, Issue 10, 2004, Pages 1369-1375

  Stewart, Robert ^a   Powell, John ^a   Prince, Martin ^a   Mann, Anthony ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

ACE genotype; African Caribbean; Cognitive decline; Polymorphism

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AFRICAN CARIBBEAN; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VERBAL MEMORY;

AFRICA; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; CARIBBEAN REGION; COGNITION DISORDERS; EDUCATIONAL STATUS; ENGLAND; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; PREVALENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 4644246569     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.02.017     Document Type: Article

References (52)

1. Alvarez R., Alvarez V., Lahoz C.H., Martínez C., Peña J., Sánchez J.M., et al. Angiotensin converting enzyme and endothelial nitric oxide symthase DNA polymorphisms and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 67:1999;733-736
2. Amouyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:1996;203-205
3. Barba R., Martínez-Espinosa S., Rodríguez-Garcia E., Pondal M., Vicancos J., Del Ser T. Poststroke dementia: clinical features and risk factors. Stroke. 31:2000;1494-1501
4. Bartrés-Faz D., Junqué C., Clemente I.C., López-Alomar A., Valveny N., López-Guillén A., et al. Angiotensin I converting enzyme polymorphism in humans with age-associated memory impairment: relationship with cognitive performance. Neurosci. Lett. 290:2000;177-180
5. Bartrés-Faz D., Junqué C., Clemente I.C., Serra-Grabulosa J.M., Guardia J., López-Alomar A., et al. MRI and genetic correlates of cognitive function in elders with memory impairment. Neurobiol. Aging. 22:2001;449-459
6. Carbonell J., Allen R., Kalsi G., McQuillin A., Livingston G., Katona C., et al. Variation in the DCP1 gene, encoding the angiotensin converting enzyme ACE, is not associated with increased susceptibility to Alzheimer's disease. Psychiatr. Genet. 13:2003;47-50
7. Chapman J., Wang N., Treves T.A., Korczyn A.D., Bornstein N.M. ACE, MHTFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke. 29:1998;1401-1404
8. Chaturvedi N., McKeigue P.M., Marmot M.G. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans. Hypertension. 22:1993;90-96
9. Cheng C.Y., Hong C.J., Liu H.C., Liu T.Y., Tsai S.J. Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. Eur. Neurol. 47:2002;26-29
10. Choi Y.H., Kim J.H., Kim D.K., Kim J.W., Kim D.K., Lee M.S., et al. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J. Gerontol. (A). 58:2003;225-226
11. Crawford F., Abdullah L., Schinka J., Suo Z., Gold M., Duara R., et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci. Lett. 280:2000;215-219
12. Farrer L.A., Sherbatich T., Keryanov S.A., Korovaitseva G.I., Rogaeva E.A., Petruk S., et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch. Neurol. 57:2000;210-214
13. Folstein M., Folstein S., McHugh P. 'Mini-Mental State', a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198
14. Forrester T., McFarlane-Anderson N., Bennett F.I., Wilks R., Cooper R., Rotimi C., et al. The angiotensin converting enzyme and blood pressure in Jamaicans. Am. J. Hypertens. 10:1997;519-524
15. Frederiksen H., Gaist D., Bathum L., Andersen K., McGue M., Vaupel J.W., et al. Angiotensin I-converting enzyme (ACE) gene polymorphism in relation to physical performance. Ann. Epidemiol. 13:2003;57-65
16. Gard P.R. The role of angiotensin II in cognition and behaviour. Eur. J. Pharmacol. 438:2002;1-14
17. Harrap S.B., Tzourio C., Cambien F., Poirier O., Raoux S., Chalmers J., et al. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension. 42:2003;297-303
18. Hassan A., Lansbury A., Catto A.J., Guthrie A., Spencer J., Craven C., et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J. Neurol. Neurosurg. Psychiatry. 72:2002;343-346
19. Hofman A., Ott A., Breteler M.M.B., Bots M.L., Slooter A.J., van Harskamp F., et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 349:1997;151-154
20. Hu J., Miyatake F., Aizu Y., Nakagawa H., Nakamura S., Tamaoka A., et al. Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci. Lett. 277:1999;65-67
21. Isbir T., Agachan B., Yilmaz H., Aydin M., Kara I., Eker D., et al. Interaction between apolipoprotein-E and angiotensin-converting enzyme genotype in Alzheimer's disease. Am. J. Alzheimer Dis. Other Dementias. 16:2001;205-210
22. Kehoe P.G., Russ C., McIlroy S., Williams H., Holmans P., Homes C., et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer's disease. Nature Genet. 21:1999;71-72
23. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function. JAMA. 274:1995;1846-1851
24. Markus H., Kapozsta Z., Ditrich R., Wolfe C., Ali N., Powell J., et al. Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms. Stroke. 32:2001;2465-2471
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944
26. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., et al. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 35:2003;901-918
27. Monastero R., Caldarella R., Mannino M., Cefalu A.B., Lopez G., Noto D., et al. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci. Lett. 335:2002;147-149
28. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part 1. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 39:1989;1159-1165
29. Myllykangas L., Polvikoski T., Sulkava R., Verkkoniemi A., Tienari P., Niinistö L., et al. Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. Neurosci. Lett. 292:2000;195-198
30. Narain Y., Yip A., Murphy T., Brayne C., Easton D., Grimley Evans J., et al. The ACE gene and Alzheimer's disease susceptibility. J. Med. Genet. 37:2000;695-697
31. Ott A., Stolk R.P., van Harskamp F., Pols H.A.P., Hofman A., Breteler M.M.B. Diabetes mellitus and the risk of dementia. Neurology. 53:1999;1937-1942
32. Pasha M.A., Khan A.P., Kumar R., Ram R.B., Grover S.K., Srivastava K.K., et al. Variations in angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian populations of different ethnic origins. J. Biosci. 27(Suppl. 1):2002;67-70
33. Reitan R, Wolfson M. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tuscon: Neuropsychology Press; 1985.
34. Richard F, Berr C, Amant C, Helbecque N, Amouyel P, Alpérovitch A, EVA Study Group. Effect of the angiotensin I-converting enzyme I/D polymorphism on cognitive decline. Neurobiol Aging 2000;21:75-80.
35. Richard F., Fromentin-David I., Ricolfi F., Ducimetière P., Di Menza C., Amouyel P., et al. The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology. 56:2001;1593-1595
36. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:1992;1433
37. Rotimi C., Puras A., Cooper R., McFarlane-Anderson N., Forrester T., Ogunbiyi O., et al. Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans and African Americans. Hypertension. 27:1996;558-563
38. Sagnella G.A., Rothwell M.J., Onipinla A.K., Wicks P.D., Cook D.G., Cappucio F.P. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J. Hypertens. 17:1999;657-664
39. Scacchi R., De Bernardini L., Mantuano E., Vilardo T., Donini L.M., Ruggeri M., et al. DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dementia Geriatr. Cogn. Dis. 9:1998;186-190
40. Shanmugam V., Sell K.W., Saha B.K. Mistyping ACE heterozygotes. PCR Methods Appl. 3:1993;120-121
41. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 64:1998;227-230
42. Sierra C., Coca A., Gómez-Angelats E., Poch E., Sobrino J., de la Sierra A. Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension. Hypertension. 39:2002;343-347
43. Stewart J.A., Dundas R., Howard R.S., Rudd A.G., Wolfe C.D.A. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ. 318:1999;967-971
44. Stewart R., Prince M., Mann A. Age, vascular risk, and cognitive decline in an older, British African-Caribbean population. J. Am. Geriatr. Soc. 51:2003;1547-1553
45. Stewart R., Richards M., Brayne C., Mann A. Vascular risk and cognitive impairment in an older, British, African-Caribbean population. J. Am. Geriatr. Soc. 49:2001;263-269
46. Welsh K.A., Fillenbaum G., Wilkinson W., Heyman A., Mohs R.C., Stern Y., et al. Neuropsychological test performance in African-American and white patients with Alzheimer's disease. Neurology. 45:1995;2207-2211
47. Whitty C.J., Brunner E.J., Shipley M.J., Hemingway H., Marmot M.G. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study. Atherosclerosis. 142:1999;279-286
48. Wild S., McKeigue P.M. Cross sectional analysis of mortality by country of birth in England and Wales, 1970-92. BMJ. 314:1997;705-710
49. Wright J.W., Reichert J.R., Davis C.J., Harding J.W. Neural plasticity and the brain renin-angiotensin system. Neurosci. Biobehav. Rev. 26:2003;529-552
50. Yang J.D., Feng G., Zhang J., Lin Z.X., Shen T., Breen G., et al. Association between angiotensin-converting enzyme gene and late onset Alzheimer's disease in Han Chinese. Neurosci. Lett. 295:2000;41-44
51. Yip A.G., Brayne C., Easton D., Rubinsztein D.C. Medical Research Council Cognitive Function and Ageing Study. An investigation of ACE as a risk factor for dementia and cognitive decline in the general population. J. Med. Genet. 39:2002;403-406
52. Zuliani G., Ble A., Zanca R., Munari M.R., Zurlo A., Vavalle C., et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol. Scand. 103:2001;304-308